14 analysts have shared their evaluations of Legend Biotech (NASDAQ:LEGN) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 8 | 6 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 2 | 0 | 0 | 0 |
2M Ago | 3 | 2 | 0 | 0 | 0 |
3M Ago | 3 | 2 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $77.93, a high estimate of $90.00, and a low estimate of $67.00. Witnessing a positive shift, the current average has risen by 1.71% from the previous average price target of $76.62.
Exploring Analyst Ratings: An In-Depth Overview
Login or create a forever free account to read this news
Sign up/Log in